000			02006 a2200625 4500
005			20250517040628.0
264		0	_c20161213
008			201612s 0 0 eng d
022			_a2040-2058
024	7		_a10.3851/IMP2976 _2doi
040			_aNLM _beng _cNLM
100	1		_aKinugasa, Hideaki
245	0	0	_aLow frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype-1 infection. _h[electronic resource]
260			_bAntiviral therapy _c2016
300			_a37-44 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAmino Acid Substitution
650	0	4	_aAntiviral Agents _xpharmacology
650	0	4	_aBiomarkers
650	0	4	_aCarbamates
650	0	4	_aDrug Resistance, Viral
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xdrug effects
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aIsoquinolines _xpharmacology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aPyrrolidines
650	0	4	_aRetreatment
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTime Factors
650	0	4	_aTreatment Failure
650	0	4	_aTreatment Outcome
650	0	4	_aValine _xanalogs & derivatives
650	0	4	_aViral Load
650	0	4	_aViral Nonstructural Proteins _xgenetics
700	1		_aIkeda, Fusao
700	1		_aTakaguchi, Kouichi
700	1		_aMori, Chizuru
700	1		_aMatsubara, Takehiro
700	1		_aShiraha, Hidenori
700	1		_aTakaki, Akinobu
700	1		_aIwasaki, Yoshiaki
700	1		_aToyooka, Shinichi
700	1		_aYamamoto, Kazuhide
773	0		_tAntiviral therapy _gvol. 21 _gno. 1 _gp. 37-44
856	4	0	_uhttps://doi.org/10.3851/IMP2976 _zAvailable from publisher's website
999			_c25021104 _d25021104